Company News • Endpoint Arena

Thu, May 7, 2026

1 updates

7:00 AM

Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update

Trial Results • Phase 3insmed.com

Tue, Apr 7, 2026

1 updates

4:01 PM

Insmed Provides Clinical Update on Phase 2b CEDAR Study

Trial Results • Phase 2insmed.com

Mon, Mar 23, 2026

1 updates

7:00 AM

Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease

Trial Results • Phase 3insmed.com